C&C Vision Changes Name to eyeonics, inc.; Name Change Reflects Corporate Commitment to Vision Enhancement Technology.

Business Editors

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Oct. 1, 2003

C&C Vision, developer of the Crystalens(TM), the first and only accommodating intraocular lens in the U.S. that enables cataract patients to see up close, far away and everything in between, today announced that it has formally changed its named to eyeonics, inc. The Crystalens is pending FDA approval.

"Our new name clearly communicates what we do and provides a meaningful statement regarding the category of vision enhancement we are committed to," said J. Andy Corley, CEO of eyeonics. "We wanted to establish a corporate name and an identity that defines the company as the developer of a new category of vision enhancement," he finished.

eyeonics was founded in 1998 by CEO J. Andy Corley and Chief Scientific Officer and developer of the Crystalens technology, Dr. J. Stuart Cumming, an ophthalmic surgeon, for the purpose of developing vision enhancement technologies that offer patients improved vision at all distances, without glasses. "The Crystalens, the first and only accommodating intraocular lens that enables patients to see clearly up close, far away and at all points in between following cataract removal, and is the result of more than 14 years of research and development," said Dr. Cumming.

During clinical trials, 98 percent of the patients who received the Crystalens greatly reduced their need for corrective lenses. By using the eye's muscle to move the lens backwards and forwards naturally, patients can focus seamlessly through a full range of vision including near, intermediate and far distances. Patients experience the same vision they had when they were younger, for most without the hassles of corrective lenses.

Currently, cataract surgery is the most common surgery performed in the U.S. today, with more than 2.7 million procedures performed annually. In addition, the National Institutes of Health estimates that 20.5 million people aged 40 and older have or are beginning to develop cataracts.

About eyeonics, inc.

eyeonics, inc., a privately held venture backed medical device company headquartered in Aliso Viejo, California, was founded in 1998. eyeonics is committed to developing a new class of visual enhancement systems that will enable patients to see up close, far away and everything in between. eyeonics is currently awaiting approval of its first U.S. product, the Crystalens Accommodating Intraocular Lens, and has also been issued 25 patents with 51 pending. eyeonics currently has 40 employees and maintains a manufacturing facility in California and a sales office in Rome, Italy. Worldwide more than 6,000 lenses have been implanted to date. For more information about eyeonics, inc. and the Crystalens technology, go to www.eyeonics.com.